AX Form 144: Insider Sale Notice of 620 Shares (Sep 2025)
Form 144 notice summary: This filing notifies a proposed sale of 620 shares of the issuer's common stock through Morgan Stanley Smith Barney LLC on 09/03/2025.
Rhea-AI Filing Summary
Form 144 notice summary: This filing notifies a proposed sale of 620 shares of the issuer's common stock through Morgan Stanley Smith Barney LLC on 09/03/2025. The shares were acquired as restricted stock on 08/01/2021 from the issuer and carry an aggregate market value of $56,110.00. The record shows 4,380 shares were sold on 09/02/2025 by Nicholas Mosich for gross proceeds of $394,253.50. The total number of shares outstanding is listed as 56,486,144. The filer represents, by signing the notice, that they do not possess any undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small-volume insider sale disclosed; transaction size is modest relative to shares outstanding and likely neutral for valuation.
The filing documents a proposed sale of 620 restricted shares acquired in 2021 and an immediate prior sale of 4,380 shares. Compared with the stated 56,486,144 shares outstanding, these transactions represent a de minimis portion of the float. The details include broker (Morgan Stanley Smith Barney LLC), dates of sale, and gross proceeds for the prior sale ($394,253.50), which provide transparency about insider liquidity. Absent additional context about timing, intent, or a larger pattern of disposals, the direct market impact appears limited. This is a routine disclosure under Rule 144.
TL;DR: Proper Rule 144 disclosure completed; no disclosed material adverse information and signature language included.
The form indicates compliance with Rule 144 reporting requirements: description of the securities, acquisition date (08/01/2021), nature of acquisition (Restricted Stock), broker information, and recent prior sale data. The filing includes the standard attestation that the seller is unaware of undisclosed material adverse information. From a governance perspective, the filing meets procedural expectations. There is no disclosure here of trading-plan adoption dates or other governance actions that would materially change assessment.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What securities are being sold in the AX Form 144 filing?
Who is the seller named in the Form 144?
What broker is handling the proposed sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.